Vident Investment Advisory, LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 211 filers reported holding BEAM THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$357,655
-1.5%
11,205
-5.5%
0.01%0.0%
Q1 2023$363,061
+9.0%
11,857
+39.2%
0.01%
-7.7%
Q4 2022$333,218
+59.4%
8,520
+4.2%
0.01%
+85.7%
Q3 2022$209,000
-1.4%
8,177
+47.4%
0.01%
+16.7%
Q2 2022$212,000
-23.2%
5,548
+15.0%
0.01%
-14.3%
Q1 2022$276,000
-32.8%
4,825
-6.5%
0.01%
-36.4%
Q4 2021$411,000
+30.1%
5,160
+110.4%
0.01%
+10.0%
Q2 2021$316,0002,4530.01%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders